ANI Pharmaceuticals, Inc. (ANIP)

Market Cap	1.78B
Revenue (ttm)	826.88M
Net Income (ttm)	34.15M
Shares Out	20.90M
EPS (ttm)	1.67
PE Ratio	50.92
Forward PE	11.01
Dividend	n/a
Ex-Dividend Date	n/a

Volume	689,613
Open	84.70
Previous Close	85.03
Day's Range	83.99 - 85.87
52-Week Range	54.10 - 99.50
Beta	0.51
Analysts	Strong Buy
Price Target	105.83 (+24.08%)
Earnings Date	Feb 27, 2026

About ANIP

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. It markets, sells, and distributes its products through wholesalers, retail market chains, distributors and specialty pharmacies, group pu...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2001
• Employees: 897
• Stock Exchange: NASDAQ
• Ticker Symbol: ANIP
• Website: https://www.anipharmaceuticals.com

Analyst Summary

According to 6 analysts, the average rating for ANIP stock is "Strong Buy." The 12-month stock price target is $105.83, which is an increase of 24.08% from the latest price.

Price Target

$105.83

(24.08% upside)

Analyst Consensus: Strong Buy